Early Detection Research Network

Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.

No abstract available.

Ali S, Berchuck A, Calingaert B, Chenevix-Trench G, Gertig D, Halabi S, Henriott A, Kelemen L, Marks J, Purdie DM, Rodriguez GC, Schildkraut JM, Spurdle AB, Wenham RM


Cancer Epidemiol. Biomarkers Prev., 2004, 13 (12)